HB1 was perhaps the hottest topic under debate during this year’s legislative session. However, even though Governor Nathan Deal is signing HB1 into law today, questions still remain about the medical uses of cannabis oil.
Clayton State University Professor and pharmacologist Dr. Peter Fitzpatrick says that, in addition to the emotional aspects of the subject of medical marijuana, the science on this issue is very conflicted.
“There appears to be a number of medical conditions that can benefit from its use, but a risk vs. benefits assessment needs to be done on a case by case basis,” he says.
Fitzpatrick is available for interview on the medical side of the debate by contacting John Shiffert in Marketing and Communications at Clayton State.
Prior to entering academia, Fitzpatrick spent years working in the pharmacy industry at all levels from store management to ownership, up to the level of Vice-President of Pharmacy and Human Resources for Courtesy Drugs, Inc. He is currently licensed to practice pharmacy in New York, South Carolina, and Georgia. He continues to practice pharmacy on a consultancy basis and also teaches Pharmacology for the Dental Hygiene program at Clayton State. He has also appeared on local TV news, discussing the issue of overuse of prescription drugs.
Fitzpatrick received his Bachelor's of Science degree in Pharmacy from St. John's University. He subsequently earned Master's degrees from Long Island University and Columbia University. He also earned his Doctoral degree from Columbia University.